Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 5:29 pm Sale |
2024-09-30 | 13G | Alimera Sciences, Inc. ALIM |
Stonepine Capital Management, LLC | 0 0.000% |
-5,373,732 (Position Closed) |
Filing History |
| 2024-11-07 11:03 am Sale |
2024-09-30 | 13G | Alimera Sciences, Inc. ALIM |
Boothbay Fund Management LLC | 0 0.000% |
-3,198,708 (Position Closed) |
Filing History |
| 2024-09-18 4:30 pm Sale |
2024-09-16 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 0 0.000% |
-17,635,154 (Position Closed) |
Filing History |
| 2024-09-16 5:10 pm Sale |
2024-09-16 | 13D | Alimera Sciences, Inc. ALIM |
Velan Capital Investment Management LP | 0 0.000% |
-14,456,510 (Position Closed) |
Filing History |
| 2024-06-24 7:30 pm Unchanged |
2024-06-21 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 17,635,154 33.200% |
0 (Unchanged) |
Filing History |
| 2024-05-16 5:06 pm Purchase |
2024-05-14 | 13D | Alimera Sciences, Inc. ALIM |
Velan Capital Investment Management LP | 14,456,510 27.200% |
846,152 (+6.22%) |
Filing History |
| 2024-02-14 1:05 pm Sale |
2023-12-31 | 13G | Alimera Sciences, Inc. ALIM |
LYTTON LAURENCE W | 2,185,364 4.200% |
-799,439 (-26.78%) |
Filing History |
| 2024-02-13 4:43 pm Sale |
2023-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Boothbay Fund Management LLC | 3,198,708 6.100% |
-1,585,772 (-33.14%) |
Filing History |
| 2024-02-13 4:24 pm Sale |
2023-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Stonepine Capital Management, LLC | 5,373,732 9.990% |
-3,979 (-0.07%) |
Filing History |
| 2024-02-13 4:06 pm Purchase |
2023-12-31 | 13G | Alimera Sciences, Inc. ALIM |
HBM BIOVENTURES CAYMAN LTD | 466,666 0.900% |
466,666 (New Position) |
Filing History |
| 2024-02-13 3:27 pm Sale |
2023-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Altium Capital Management LLC | 2,660,000 5.000% |
-324,803 (-10.88%) |
Filing History |
| 2023-12-08 4:11 pm Purchase |
2023-11-30 | 13G | Alimera Sciences, Inc. ALIM |
MORGAN STANLEY MS |
916,246 1.800% |
250,000 (+37.52%) |
Filing History |
| 2023-08-23 06:01 am Purchase |
2023-08-15 | 13G | Alimera Sciences, Inc. ALIM |
Altium Capital Management LLC | 2,984,803 5.700% |
2,984,803 (New Position) |
Filing History |
| 2023-08-16 5:17 pm Unchanged |
2023-08-15 | 13D | Alimera Sciences, Inc. ALIM |
Velan Capital Investment Management LP | 13,610,358 26.000% |
0 (Unchanged) |
Filing History |
| 2023-08-14 12:20 pm Purchase |
2023-08-02 | 13G | Alimera Sciences, Inc. ALIM |
LYTTON LAURENCE W | 2,984,803 5.700% |
2,984,803 (New Position) |
Filing History |
| 2023-08-10 5:26 pm Purchase |
2023-08-02 | 13G | Alimera Sciences, Inc. ALIM |
Stonepine Capital Management, LLC | 5,377,711 9.990% |
5,377,711 (New Position) |
Filing History |
| 2023-08-10 4:57 pm Purchase |
2023-08-01 | 13G | Alimera Sciences, Inc. ALIM |
Boothbay Fund Management LLC | 4,784,480 8.990% |
4,784,480 (New Position) |
Filing History |
| 2023-08-03 4:30 pm Sale |
2023-08-01 | 13D | Alimera Sciences, Inc. ALIM |
Caligan Partners LP | 17,635,154 33.100% |
-915,040,279,903 (-100.00%) |
Filing History |
| 2023-08-03 4:00 pm Purchase |
2023-08-01 | 13D | Alimera Sciences, Inc. ALIM |
Velan Capital Investment Management LP | 13,610,358 26.000% |
11,948,879 (+719.17%) |
Filing History |
| 2023-05-19 4:00 pm Purchase |
2023-05-17 | 13D | Alimera Sciences, Inc. ALIM |
Velan Capital Investment Management LP | 1,661,479 18.900% |
911,729 (+121.60%) |
Filing History |